'Achilles heel' of antibiotic-resistant bacteria discovered
Researchers at UC San Diego found that antibiotic-resistant bacteria depend on magnesium, suggesting that manipulating magnesium levels could provide new treatment strategies against infections without traditional antibiotics.
Read original articleResearchers at the University of California San Diego have identified a significant vulnerability in antibiotic-resistant bacteria, which could lead to new treatment strategies. The study, published in Science Advances, reveals that antibiotic-resistant strains, such as Bacillus subtilis, exhibit a dependency on magnesium due to mutations that confer resistance. This dependency creates competition for magnesium between ribosomes, which are essential for protein synthesis, and ATP molecules, the cell's energy source. As a result, resistant bacteria become less efficient in low-magnesium environments, despite their resistance to antibiotics. This discovery suggests that manipulating magnesium levels could be a novel approach to combat antibiotic-resistant infections without relying on traditional antibiotics. The findings highlight the need for drug-free alternatives in the face of rising antibiotic resistance, which currently claims over one million lives annually and is projected to increase significantly by 2050. The research underscores the potential of targeting the physiological trade-offs in resistant bacteria to develop effective treatments.
- Researchers discovered a vulnerability in antibiotic-resistant bacteria related to magnesium dependency.
- The study suggests manipulating magnesium levels could help control resistant strains without antibiotics.
- Current antibiotic resistance is a major global health issue, with over one million deaths annually.
- The findings indicate a need for drug-free alternatives to combat bacterial infections.
- The research highlights the trade-off between antibiotic resistance and cellular efficiency in low-magnesium environments.
Related
Bye Bye Superbugs? New Antibiotic Is Virtually Resistance-Proof
A new class of antibiotics, macrolones, shows promise against antimicrobial resistance by using a dual-target approach. Developed by researchers, they effectively combat resistant bacteria, offering hope for future treatments.
Dual action antibiotic could make bacterial resistance nearly impossible
Researchers at the University of Illinois Chicago developed macrolones, a new antibiotic class that targets protein production and DNA structure, significantly reducing bacterial resistance and showing promise for further development.
Dual-action antibiotic could make bacterial resistance nearly impossible
Researchers at UIC developed macrolones, a dual-action antibiotic that targets bacterial functions, making resistance 100 million times harder. This approach shows promise in combating antibiotic resistance effectively.
Revolutionary Dual Action Antibiotic Makes Bacterial Resistance Nearly Impossibl
Researchers at the University of Illinois Chicago have developed macrolones, synthetic antibiotics that disrupt protein production and DNA structure, making it harder for bacteria to develop resistance.
Study reveals superbug MRSA's double defense against antibiotics
Researchers at the University of Sheffield discovered MRSA's dual defense mechanism against antibiotics, revealing a new survival strategy that could inform the development of effective treatments and new antibiotics.
Very annoying writing style to the article
Magnesium deprivation stops pathogen growth - November 21, 2019
Related
Bye Bye Superbugs? New Antibiotic Is Virtually Resistance-Proof
A new class of antibiotics, macrolones, shows promise against antimicrobial resistance by using a dual-target approach. Developed by researchers, they effectively combat resistant bacteria, offering hope for future treatments.
Dual action antibiotic could make bacterial resistance nearly impossible
Researchers at the University of Illinois Chicago developed macrolones, a new antibiotic class that targets protein production and DNA structure, significantly reducing bacterial resistance and showing promise for further development.
Dual-action antibiotic could make bacterial resistance nearly impossible
Researchers at UIC developed macrolones, a dual-action antibiotic that targets bacterial functions, making resistance 100 million times harder. This approach shows promise in combating antibiotic resistance effectively.
Revolutionary Dual Action Antibiotic Makes Bacterial Resistance Nearly Impossibl
Researchers at the University of Illinois Chicago have developed macrolones, synthetic antibiotics that disrupt protein production and DNA structure, making it harder for bacteria to develop resistance.
Study reveals superbug MRSA's double defense against antibiotics
Researchers at the University of Sheffield discovered MRSA's dual defense mechanism against antibiotics, revealing a new survival strategy that could inform the development of effective treatments and new antibiotics.